Sofwave Receives FDA Clearance for Pure ImpactTM in Strengthening and Firming of Arms in the U.S
Game-Changing Wrinkle Reduction Device Receives Key Regulatory Clearance in Canada
Date
Sofwave is crucial to your aesthetic practice. Learn Why!
YOQNEAM, Israel, Feb. 24, 2021 /PRNewswire/ — Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received clearance from Health Canada for its next-generation Sofwave system. Aesthetic practices adding Sofwave to their service menu will be able to offer a noticeable wrinkle reduction in a single treatment through the industry’s most innovative energy-based treatment.
Sharyn A Laughlin M.D.According to Sharyn A Laughlin M.D., a leading expert in the field of dermatology and Medical Director of Laserderm, this new device meets an unmet need. ” “Using Sofwave I can give my patients impressive results in one treatment session.”
Jay Herman, President of Salient Medical“Sofwave has been the most anticipated introduction of non-invasive aesthetic devices since its introduction and rapid adoption in the US,” said Jay Herman, President of Salient Medical. “We are excited to partner with Sofwave and be able to provide this opportunity to physicians across Canada to enhance their practice.”
Louis ScafuriChief Executive Officer of Sofwave MedicalLouis Scafuri, Chief Executive Officer of Sofwave Medical, calls the clearance for Sofwave technology “an important milestone for the company,” adding that the new technology “targets a growing customer base of patients who are looking to reduce their wrinkles and facial lines with non-invasive technology.”
Sofwave’s state-of-the-art Synchronous Ultrasound Parallel Beam technology SUPERBTM addresses the growing demand for non-invasive treatments that deliver noticeable wrinkle reduction. The device’s seven cooled transducers are directly coupled to the epidermis, creating a unique 3D array of volumetric thermal zones that deliver parallel energy simultaneously, resulting in significant collagen remodeling in the mid-dermis. A single Sofwave treatment reduces facial wrinkles in a fast 30 to 45minute non-invasive treatment with minimal downtime or post-treatment discomfort.
About Sofwave Medical Ltd.
Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction using proprietary breakthrough technology. Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients.
References
- "Game-Changing Wrinkle Reduction Device Receives Key Regulatory Clearance in Canada", Feb 24, 2021, Cision US
Read More
Sofwave Medical Reports Second Quarter and First Half 2024 Financial Results and Business Highlights
Sofwave Names Larry Laber, Aesthetic Energy-Based Device Sales Veteran, to Role of Executive Vice President, North American Sales
Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights
Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
